TACR1
MOLECULAR TARGETtachykinin receptor 1
TACR1 (tachykinin receptor 1) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TACR1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Substance P | 3.43 | 30 |
| 2 | Aprepitant | 3.00 | 19 |
| 3 | Neurokinin | 2.08 | 7 |
| 4 | Neurokinin B | 1.95 | 6 |
| 5 | Amoxapine | 0.69 | 1 |
| 6 | Aripiprazole | 0.69 | 1 |
| 7 | Astemizole Antihistamine drug now withdrawn from | 0.69 | 1 |
| 8 | Carvedilol | 0.69 | 1 |
| 9 | Dextromethorphan Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of | 0.69 | 1 |
| 10 | Eledoisin | 0.69 | 1 |
| 11 | Fidaxomicin | 0.69 | 1 |
| 12 | Kassinin Dodecapeptide tachykinin found in | 0.69 | 1 |
| 13 | neurokinin 1 receptor antagonists | 0.69 | 1 |
| 14 | Ritonavir | 0.69 | 1 |
| 15 | Trazodone | 0.69 | 1 |
About TACR1 as a Drug Target
TACR1 (tachykinin receptor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented TACR1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TACR1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.